Related Experiment Video
Updated: Jan 17, 2026
07:41
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
9.4K
G Protein-Coupled Receptor Signaling: Implications and Therapeutic Development Advances in Cancers
Inamu Rashid Khan1, Sana Khurshid2, Saud Almawash3
1Department of Zoology Central University of Kashmir Ganderbal Kashmir India.
Medcomm
|September 19, 2025
Summary
G protein-coupled receptors (GPCRs) are key membrane proteins involved in cancer. Understanding their complex signaling pathways, particularly biased signaling, is crucial for developing targeted cancer therapies.
Area of Science:
- Molecular Biology
- Cellular Biology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) are a large class of membrane proteins mediating cellular responses.
- GPCRs regulate vital physiological functions and are implicated in various diseases, including cancer.
- Abnormal GPCR signaling in tumors promotes carcinogenesis by influencing immune evasion, proliferation, and therapeutic resistance.
Purpose of the Study:
- To review the complexity of GPCRs and their role in cancer signaling.
- To focus on differential pathway activation by G proteins and β-arrestin.
- To explore targeted modulation of GPCR signaling for cancer treatment.
Main Methods:
- Literature review of GPCR structure-function relationships.
- Analysis of GPCR-biased signaling mechanisms.
- Examination of emerging technologies for GPCR targeting.
Main Results:
- GPCRs' seven-transmembrane structure facilitates diverse signaling networks.
- Pathway-specific GPCR activation and biased ligand discovery are critical research areas.
- Targeted modulation of GPCR signaling pathways shows therapeutic potential in cancer.
Conclusions:
- Understanding GPCR-biased signaling offers insights into cancer biology.
- Emerging technologies like aptamers, PROTACs, and nanobodies enable precise GPCR targeting.
- Modulating GPCR signaling pathways may lead to more effective cancer therapies.
Related Concept Videos
01:15G Protein-coupled Receptors
16.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.6K
01:22Amplifying Signals via Enzymatic Cascade
17.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
01:30Transducer Mechanism: G Protein–Coupled Receptors
4.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.0K